Overview

Symptomatic Treatment of Vascular Cognitive Impairment

Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
Single center threeway double blind cross over trial investigating the pharmacological responsivity in patients with VCI using a challenge aimed at the monoaminergic and cholinergic neuronal systems
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
VU University Medical Center
Treatments:
Galantamine
Methylphenidate